• Mixed data for Xencor’s SLE drug pharmatimes
    October 11, 2018
    Xencor’s experimental systemic lupus erythematosus (SLE) drug XmAb5871 has failed to hit its key target in a mid-stage study.
PharmaSources Customer Service